Corticosteroid-resistant Terbinafine-induced Acute Generalized Exanthematous Pustulosis: Therapeutic Challenges and Clinical Infection Overlap
DOI:
https://doi.org/10.2340/actadv.v106.adv-2026-0360Keywords:
Drug side effects, sensitive skin, psoriasis, psoriasis Agep, atopic dermatitis, Acute Generalized Exanthematous Pustulosis, Drug Eruption, Drug Hypersensitivity, antifungals, terbinafineDownloads
References
Ross CL, Shevchenko A, Mollanazar NK, Hsu S, Motaparthi K. Acute generalized exanthematous pustulosis due to terbinafine. Dermatol Ther 2018; 31: e12617. DOI: https://doi.org/10.1111/dth.12617
Carnio LR, Johnson Shaw ME, Schnur J, Casadesus D. Concurrent terbinafine-induced acute generalised exanthematous pustulosis and hepatitis. BMJ Case Rep 2021; 60: e238930. DOI: https://doi.org/10.1136/bcr-2020-238930
Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC. Acute generalized exanthematous pustulosis (AGEP)--a clinical reaction pattern. J Cutan Pathol 2001; 28: 113–119. DOI: https://doi.org/10.1034/j.1600-0560.2001.028003113.x
de Oliveira GV, Maia MLP, Leão FAA, Sad EF, Miotto IZ, Silva MR, et al. What to expect when AGEP is induced by terbinafine? Case report and critical review of the literature. Mycoses 2022; 65: 918–925. DOI: https://doi.org/10.1111/myc.13506
Yanes D, Nguyen E, Imadojemu S, Kroshinsky D. Cyclosporine for treatment of acute generalized exanthematous pustulosis: a retrospective analysis. J Am Acad Dermatol 2020; 83: 263–265. DOI: https://doi.org/10.1016/j.jaad.2020.02.069
Published
How to Cite
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.